A comprehensive analysis of the faecal microbiome and metabolome of Strongyloides stercoralis infected volunteers from a non-endemic area by Jenkins, Timothy P et al.
1SCIeNTIfIC REPORTs |  (2018) 8:15651  | DOI:10.1038/s41598-018-33937-3
www.nature.com/scientificreports
A comprehensive analysis of 
the faecal microbiome and 
metabolome of Strongyloides 
stercoralis infected volunteers from 
a non-endemic area
Timothy P. Jenkins  1, Fabio Formenti  2, Cecilia Castro3, Chiara Piubelli  2, 
Francesca Perandin2, Dora Buonfrate2, Domenico Otranto4, Julian L. Griffin3, Lutz Krause  5, 
Zeno Bisoffi2,6 & Cinzia Cantacessi  1
Data from recent studies support the hypothesis that infections by human gastrointestinal (GI) 
helminths impact, directly and/or indirectly, on the composition of the host gut microbial flora. 
However, to the best of our knowledge, these studies have been conducted in helminth-endemic 
areas with multi-helminth infections and/or in volunteers with underlying gut disorders. Therefore, 
in this study, we explore the impact of natural mono-infections by the human parasite Strongyloides 
stercoralis on the faecal microbiota and metabolic profiles of a cohort of human volunteers from a 
non-endemic area of northern Italy (S+), pre- and post-anthelmintic treatment, and compare the 
findings with data obtained from a cohort of uninfected controls from the same geographical area (S−). 
Analyses of bacterial 16S rRNA high-throughput sequencing data revealed increased microbial alpha 
diversity and decreased beta diversity in the faecal microbial profiles of S+ subjects compared to S−. 
Furthermore, significant differences in the abundance of several bacterial taxa were observed between 
samples from S+ and S− subjects, and between S+ samples collected pre- and post-anthelmintic 
treatment. Faecal metabolite analysis detected marked increases in the abundance of selected amino 
acids in S+ subjects, and of short chain fatty acids in S− subjects. Overall, our work adds valuable 
knowledge to current understanding of parasite-microbiota associations and will assist future 
mechanistic studies aimed to unravel the causality of these relationships.
The human gastrointestinal (GI) tract is inhabited by a myriad of bacteria, viruses, archaea, fungi, and other 
unicellular and multicellular microorganisms, that together form the gut micro- and macrobiota1–4. Whilst 
some members of the microbiota can cause severe disease5, most resident bacteria exert a number of special-
ised functions that are beneficial to the human host, including absorption of nutrients, synthesis of essential 
organic compounds, development of adaptive immunity and protection against pathogens6–9. Disturbances of 
the composition of the gut microbiota (i.e. dysbiosis) have been unequivocally linked to the onset of a range 
of gut and systemic diseases, such as chronic autoimmune and allergic disorders, obesity, diabetes and, more 
recently, multiple sclerosis (MS)10–13. On the other hand, with a few exceptions, multicellular organisms residing 
in the GI tract, such as parasitic worms (=helminths) are mostly considered detrimental to human health, as they 
can subtract nutrients, damage host tissues and release toxic waste products14–16. Nonetheless, in the developing 
world, infections by parasitic helminths have been associated with a low incidence of allergic and autoimmune 
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diseases, as encompassed by the ‘hygiene hypothesis’17,18; this observation has led to the ‘curative’ properties of a 
range of GI helminths being investigated in a range of clinical trials aimed to develop novel therapeutics against 
selected chronic inflammatory disorders, such as ulcerative colitis19,20, Crohn’s disease21–24, coeliac disease25,26 
and MS27–31. Whilst preliminary results from a number of such trials are promising, a thorough understanding 
of the mechanisms that determine the anti-inflammatory properties of these helminths is necessary to assist the 
development of new effective therapeutics against these disorders. These properties are predominantly attributed 
to the ability of parasites and/or their excretory/secretory products to modulate host immune responses to facil-
itate their long-term establishment in the human gut32–43; nevertheless, in recent years, the ability of controlled 
infections by selected GI helminths to ameliorate clinical signs of chronic inflammation has been hypothesized 
to stem, at least in part, from direct and/or immune-mediated interactions between parasites and the resident 
microbial flora (reviewed by44). This hypothesis is supported by observations from several studies45–50 that have 
reported associations between human infections by GI parasites (under experimental and natural settings) and 
shifts in the composition of the human gut microbiota towards a ‘healthy’ phenotype, as well as increased levels 
of metabolites with anti-inflammatory properties45–50. However, information reported to date have been derived 
from cohorts of human volunteers with underlying chronic gut disorders (e.g. coeliac disease45–48) or conditions 
of malnutrition and/or multi-specific helminth infections and/or exposed to multiple re-infections50–53, with 
likely implications on the ‘steady-state’ of the gut flora of these individuals. Whilst complete elimination of these 
confounding factors is difficult to achieve in human studies, investigations of the impact that infections by single 
species of GI helminths exert on the composition of the gut flora of individuals with no clinical evidence of con-
curring co-infections or underlying gut disorders may help disentangle the causality of parasite-microbiota rela-
tionships; in turn, this knowledge may assist the design of mechanistic experiments in available animal models of 
infection and disease (cf.54–57), aimed to achieve a better understanding of the therapeutic properties of parasites.
Strongyloides stercoralis is a soil transmitted intestinal nematode estimated to infect ~370 million peo-
ple worldwide, with higher prevalence (ranging from 10% to 60%) recorded across tropical and subtropi-
cal regions58–61. The life cycle of S. stercoralis is complex, in that it involves both free-living and parasitic adult 
stages58,62. In particular, the small intestine of the vertebrate hosts (e.g. humans) harbours adult females only, 
which reproduce via parthenogenesis and lay eggs that hatch immediately, releasing first stage rhabditiform lar-
vae (L1s) that are excreted with the host faeces (reviewed by58,62). However, L1s can also develop into invasive 
filariform larvae that are able to re-infect the host without being excreted (i.e. ‘autoinfection’)62. Once in the 
environment, male L1s develop through four larval stages to free-living adults; conversely, female L1s can either 
develop through to free-living adults (similarly to males) or reach a developmental stage infective to a new sus-
ceptible host, i.e. the infective third-stage larva (L3). Importantly, the new generation of female parasites deriv-
ing from sexual reproduction of free-living males and females is inevitably parasitic58,62. These infective larvae 
typically infect humans percutaneously and migrate to the small intestine, where the cycle recommences58,62. 
Autoinfection of a susceptible host can occur at a low level for several years, and is often subclinical or asymp-
tomatic58,62 although, in immunosuppressed individuals, parasites can spread to all organs and tissues causing 
(potentially fatal) ‘disseminated strongyloidiasis’.
Chronic infections by S. stercoralis provide a golden opportunity to evaluate the effect/s of long-term col-
onisation by parasitic nematodes on the composition of the human gut microbiota. In this study, we explore 
the impact of natural infections by S. stercoralis on the faecal microbiota and metabolic profiles of a cohort of 
elderly volunteers (with no clinical evidence of concurrent pathologies of infectious or non-infectious origin) 
from northern Italy. This area is non-endemic for parasitic nematodes, but characterised by the presence of spo-
radic cases of chronic infections by S. stercoralis in elderly individuals in which the parasite has persisted through 
several decades via autoinfection63. We profiled the faecal microbiota of these subjects pre- and post-anthelmintic 
treatment with ivermectin, and compared the findings with a control cohort of uninfected individuals from the 
same geographical area.
Results
The composition of the faecal microbiota of human volunteers infected by Strongyloides 
stercoralis pre- and post-anthelmintic treatment. Individual faecal samples were collected from 20 
elderly volunteers [74 ± 11 years of age (average ± standard deviation)] with confirmed infections by S. stercoralis 
(S+), as well as from 11 uninfected volunteers (S−) of comparable age and from the same geographical areas 
(Supplementary Fig. S1). Additional faecal samples were collected from 13 (out of 20) S+ subjects 6 months 
post-anthelmintic treatment. In comparative analyses of the human faecal microbiota pre- and post-treatment, 
samples from the latter 13 subjects are hereafter referred to as S+pre-treatment and S+post-treatment, respectively. A total 
of 44 faecal samples were subjected to microbial DNA extraction and high-throughput Illumina sequencing of 
the bacterial 16S rRNA gene [i.e. S+ = 20 (including S+pre-treatment = 13), S+post-treatment = 13 and S− = 11] whilst 
a total of 31 samples [i.e. S+ = 14 (including S+pre-treatment = 8), S+post-treatment = 7 and S− = 10] were subjected to 
metabolite profiling via nuclear magnetic resonance (NMR) and gas chromatography/mass spectrometry (GC-
MS) (cf. Supplementary Table S1).
High-throughput amplicon sequencing yielded a total of 5,717,403 paired-end reads (not shown), of which 
1,446,150 high-quality sequences (per sample mean 26,778 ± 13,928) were retained after quality control. 
Rarefaction curves generated following in silico subtraction of low-quality sequences indicated that the majority 
of faecal bacterial diversity was well represented by the sequence data (Supplementary Fig. S2). These sequences 
were assigned to 2,630 Operational Taxonomic Units (OTUs) and 15 bacterial phyla, respectively (data avail-
able from Mendeley Data at 10.17632/n86dtjvmbv.1). The phyla Firmicutes (64.5% average ± 14.4% standard 
deviation) and Proteobacteria (18.2 ± 12.8%) were most abundant in all samples analysed, followed by the 
phyla Actinobacteria (7.9 ± 6.4%), Verrucomicrobia (5.4 ± 7.7%) and Bacteroidetes (1 ± 1.1%) (Fig. 1). At the 
order level, Clostridiales were most abundant in all samples analysed (54.4 ± 15.2%), and included the two most 
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abundant microbial families, i.e. the Ruminococcaceae (20.6 ± 11.6%) and the Lachnospiraceae (13.4 ± 8.1%) 
(Fig. 1). Faecal microbial community profiles were ordinated by Canonical Correspondence Analysis (CCA) 
(Fig. 2a), that separated samples by infection status (S+ and S−) (effect size (F) = 1.14, P = 0.03). No statistically 
significant differences between the gut microbial composition of S+pre-treatment, S+post-treatment, and S− subjects were 
detected (F = 0.97, P = 0.64; Fig. 2b). Similarly, S+pre-treatment and S+post-treatment samples did not show any statisti-
cally significant difference in community composition (P > 0.05, CCA).
Figure 1. Firmicutes and Proteobacteria are most abundant phyla in the faecal microbiota of all study subjects. 
Relative abundances of bacterial phyla and families detected in faecal samples from Strongyloides stercoralis 
infected and uninfected subjects (S+ and S−, respectively) and of the subset of S+ subjects that had received 
anthelmintic treatment (associated sub-circles), both prior to (S+pre-treatment) and 6 months post-ivermectin 
administration (S+post-treatment). Percentages in individual pie chart sections indicate the relative proportion of a 
given bacterial phylum or family.
Figure 2. The faecal microbial profiles of Strongyloides stercoralis-infected individuals and uninfected controls. 
Differences between the faecal microbial profiles of S. stercoralis infected and uninfected subjects (S+ and S−, 
respectively) (a), and between the microbial profiles of the subset of S+ subjects that had received anthelmintic 
treatment, both prior to (S+pre-treatment) and 6 months post-ivermectin administration (S+post-treatment), and of S− 
subjects, ordinated by supervised Canonical Correspondence Analysis (CCA; b).
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Infection by Strongyloides stercoralis is associated with increased alpha diversity, and decreased 
beta diversity, of the faecal microbiota. Microbial alpha diversity, measured through Simpson’s index, 
and evenness were significantly increased in the faecal microbiota of S+ volunteers when compared to that of 
S− (F = 5, P = 0.03 and F = 4.2, P = 0.05 respectively) (Fig. 3a). Faecal microbial richness was not significantly 
different between S+ and S− subjects, albeit a trend towards increased richness in samples from S+ subjects was 
observed. Simpson diversity and richness were decreased in samples from S+post-treatment compared to S+pre-treatment, 
although only the latter was significant (P < 0.001; mixed effect linear regression) (Fig. 3b). Compared to S−, 
Figure 3. The faecal microbiome of Strongyloides stercoralis-infected subjects is characterised by increased 
alpha diversity and decreased beta diversity, respectively, when compared to that of uninfected controls. (a) 
Differences in overall microbial Simpson (alpha) diversity, and corresponding richness and evenness, between 
the faecal microbial profiles of S. stercoralis-infected and uninfected subjects (S+ and S−, respectively), and 
(b) between the faecal microbial profiles of the subset of S+ subjects that had received anthelmintic treatment, 
both prior to (S+pre-treatment) and 6 months post-ivermectin administration (S+post-treatment), and of S− subjects. (c) 
Differences in microbial beta diversity between S+ and S− samples, as well as (d) between samples from S+pre-
treatment, S+post-treatment and S−. The bold and black horizontal lines in the boxplots refer to the respective mean 
(i.e. Simpson’s Index, richness, and evenness) associated with the corresponding group, with top and bottom 
whiskers representing the standard deviation. Points connected by lines in (b) refer to samples collected from 
the same study participant pre- and post-anthelmintic treatment. Significant differences between study groups 
are marked by an asterisk (*).
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S+post-treatment samples showed a trend towards increased Simpson diversity and evenness, while richness was lower 
in samples post-treatment when compared to samples from uninfected subjects (Fig. 3b). Microbial beta diver-
sity was significantly lower in samples from S+ subjects when compared to S− subjects (effect size (R) = 0.11, 
P = 0.04; Fig. 3c), whilst beta diversity in S+post-treatment samples was higher than that in S+pre-treatment but lower than 
that in S− samples, albeit not significantly (Fig. 3d).
Strongyloides stercoralis infection is associated with expanded populations of Leuconostocaceae, 
Ruminococcaceae, Paraprevotellaceae and Peptococcus and reduced Pseudomonadales. Linear 
discriminant analysis Effect Size (LEfSe) revealed significant differences in the abundance of individual micro-
bial taxa (phylum to species level) between S+ and S− subjects (Fig. 4a). In particular, the faecal microbiota 
of S− subjects was significantly enriched for populations of bacteria belonging to the order Pseudomonadales 
(genus Pseudomonas) and an unidentified species belonging to the genus Bacteroides (Fig. 4a); conversely, bacte-
ria belonging to the families Leuconostocaceae, Ruminococcaceae, Paraprevotellaceae and to the genus Peptococcus, 
amongst others, were significantly higher in the faecal microbiota of S+ subjects (Fig. 4a). In addition, in sam-
ples from S+post-treatment subjects, a significant decrease of bacteria belonging to the order Turicibacterales (genus 
Turicibacter) and an increase of Enterobacteriales (in particular associated to the genus Shigella) were observed 
compared to corresponding samples from S+pre-treatment (Fig. 4b and Supplementary Fig. S3). Additionally, differ-
ences were observed between the microbial profiles of S+post-treatment samples when compared to S−, with the latter 
displaying increased levels of bacteria belonging to the order Pseudomonadales and genus Atopobium, as well as 
Bacteroides eggerthii, Clostridium celatum and Bifidobacterium bifidum, and decreased levels of Lachnobacterium, 
Roseburia faecis, and Eubacterium biforme, respectively (Fig. 4c).
Figure 4. Differentially abundant bacterial taxa in the faecal microbiota of Strongyloides stercoralis (a) infected 
and uninfected subjects (S+ and S−, respectively), (b) infected subjects pre- and post anthelmintic treatment 
with ivermectin (S+pre-treatment and S+post-treatment, respectively), and (c) infected subjects post-anthelmintic 
treatment and uninfected subjects (S+post-treatment and S− respectively), based on Linear discriminant analysis 
Effect Size (LEfSe) analysis. Colours correspond to Linear Discriminant Analysis (LDA) scores of 4 or higher 
(red) and 3.5 to 4 (yellow).
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The faecal metabolome of Strongyloides stercoralis infected volunteers is characterized by low 
levels of short chain fatty acids (SCFAs) and increased amino acid abundance. A total of 28 
metabolites were identified by NMR across all samples (Fig. 5a); these were subjected to Principal Coordinates 
Analysis (PCoA), which unveiled no marked differences in faecal metabolic profiles between samples from S+ 
and S− subjects, as well as from S+pre-treatment, S+post-treatment, and S− subjects (data not shown). However, asso-
ciation network analysis of S+ and S− samples indicated clustering of several faecal metabolites according to 
the infection status of the study subjects. In particular, 13 metabolites (alanine, isoleucine, glycine, phenylala-
nine, formate, valine, tyrosine, leucine, lysine, uracil, hypoxanthine, and aspartate), were positively correlated 
with each other and associated with the faecal metabolic profiles of S+ subjects (Fig. 5b), whereas four (the 
SCFAs propionate, butyrate, and acetate, as well as succinate) were also positively correlated with each other, 
and associated with faecal samples from S− subjects (Fig. 5b). When applied to the faecal metabolic profiles 
of S+pre-treatment, S+post-treatment and S− subjects, network analysis associated the 13 metabolites described above 
Figure 5. Decreased levels of selected short chain fatty acids (SCFAs) and increased levels of amino acids 
are associated with Strongyloides stercoralis infection. (a) Area plot indicating the abundance (expressed as 
percentage) of metabolites detected by nuclear magnetic resonance analysis (NMR) in faecal samples from 
S. stercoralis-infected and uninfected subjects (S+ in red, and S− in purple), as well as from the subset of S+ 
subjects that had received anthelmintic treatment, both prior to (S+pre-treatment, red sample label) and 6 months 
post-ivermectin administration (S+post-treatment, in orange). (b) Network analysis displaying associations between 
individual or clusters of metabolites and sample groups (i.e. S+ in red, S− in blue [top network], S+pre-treatment in 
red, S+post-treatment in yellow and S− in blue [bottom network]). For metabolites associated with multiple sample 
groups, the respective circle colours are mixed according to the strength of the association. (c) Differentially 
abundant metabolites detected in faecal samples from S+ and S−, as well as S+pre-treatment, S+post-treatment, and 
S− subjects, determined using ANOVA. The bold and black horizontal lines in the boxplots refer to the mean 
of percentage abundance of metabolite associated with the corresponding group, with top and bottom whiskers 
representing the standard deviation. Significant differences between study groups are marked by an asterisk (*).
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(previously associated with S+) with both S+pre-treatment and S+post-treatment, whereas the SCFAs remained associ-
ated with the metabolic profiles of S− subjects (Fig. 5b). Analysis of differentially abundant metabolites between 
S+pre-treatment, S+post-treatment, and S− samples via ANOVA further revealed that 10 (out of 12) metabolites associated 
with samples from S+post-treatment subjects were less abundant than in S+pre-treatment samples, but more abundant 
when compared to S− samples, albeit not significantly (Supplementary Fig. S4). Additionally, alanine, formate, 
lysine, and leucine were significantly more abundant in samples from S+ when compared to S− (F = 4.2, P = 0.05; 
F = 4.5, P = 0.03; F = 4.5, P = 0.05; F = 4.3, P = 0.05 respectively) whilst formate was significantly more abundant 
in S+post-treatment compared to S− subjects (F = 5.6, P = 0.01); nevertheless, these differences were not significant 
following p-value correction for multiple testing (FDR > 0.05) (Fig. 5c).
Using GC-MS, a total of 13 fatty acids were detected across all analysed faecal samples, including lauric acid 
(C12:0), myristic acid (C14:0), pentadecanoic acid (C15:0, C15:0 iso, and C15:0 ante), palmitic acid (C16:0), 
margaric acid (C17:0, C17:0 iso, C17:0 ante), stearic acid (C18:0), oleic acid (C18:1), linoleic acid (C18:2), and 
arachidic acid (C20:0) (Supplementary Fig. S5). No significant associations between any of the analysis groups 
were detected using PCoA and no significant differences in the relative abundance of individual metabolites were 
observed between samples from S+ and S− subjects, as well as S+pre-treatment, S+post-treatment, and S− subjects (data 
not shown).
Discussion
In this study, we aimed to determine the effect/s that chronic, monospecific infections by the parasitic nema-
tode S. stercoralis exert/s on the faecal microbiome and metabolome of human volunteers from a non-endemic 
area of Europe, and establish whether such effects are reversed following the administration of anthelmintic 
treatment. Whilst the overall composition of the faecal microbiota of Strongyloides-infected and uninfected vol-
unteers enrolled in this study largely reflected that of human subjects harbouring GI helminths under natu-
ral or experimental conditions of infections described in previous investigations, the relatively low proportions 
of Bacteroidetes observed in our samples contrast findings from some previously published reports47,48,50,51,53. 
However, this discrepancy may be accounted for by differences in mean age of the cohorts enrolled in our (72 
years of age) versus previous studies (i.e. 11–51 years of age; cf.47,48,50,51,53); indeed, a decline in the relative abun-
dance of Bacteroidetes in the gut microbiota of aging subjects has been documented in several studies64–67, and is 
thus considered ‘physiological’ in the age group enrolled in our experiment.
In spite of the overall similarities in the composition of the faecal microbiota of S+ and S− subjects at phy-
lum level, CCA analysis revealed differences in the microbial profiles of these two groups, thus indicating that 
S. stercoralis infection was associated with shifts in the relative abundance of individual gut bacterial species. 
Indeed, microbial alpha diversity was significantly higher in the faecal microbiota of S+ when compared to S−. 
In particular, the level of microbial alpha diversity detected in the latter group largely reflected that recorded in a 
cohort of healthy, elderly Italians investigated previously68. Conversely, microbial beta diversity was significantly 
decreased in faecal samples from S+ subjects when compared to S−. Increased levels of microbial alpha diversity 
have been repeatedly observed in the gut microbiome of human subjects infected by a range of GI helminths (i.e. 
Necator americanus, Trichuris trichiura, and Ascaris sp.)47,48,50. Since alpha diversity measures are frequently used 
as proxy of microbiome ‘health’ (with high alpha diversity associated with a mature, homogenous, stable and 
healthy gut microbial environment69,70), it has been proposed that the direct or immune-mediated ability of GI 
helminths to restore gut homeostasis by promoting increases in microbial richness and evenness may represent 
one mechanism by which parasites exert their therapeutic properties in individuals with chronic inflammatory 
disorders48,49,71.
The difference in microbial alpha and beta diversity observed between S+ and S− subjects were determined 
by dissimilarities in the relative abundance of selected bacterial taxa in the faecal microbial profiles of these study 
groups. In particular, significantly expanded populations of Clostridia and Leuconostocaceae could be detected 
in the faecal microbiota of S+ when compared to S− subjects. Notably, selected strains of Clostridia strains have 
been identified as leading players in the maintenance of gut homeostasis, due to their roles in protecting the 
gut from pathogen colonisation, mediating host immune system development and modulating immunological 
tolerance72. On the other hand, members of the Leuconostocaceae, a family of anaerobic lactic acid-producing 
bacteria, have been demonstrated to stimulate the release of inflammatory Th1 type cytokines IL-12 and IFN-γ 
by activated antigen-presenting cells in human peripheral blood mononuclear cells, thus promoting the activation 
of antimicrobial immune responses73. However, a significant decrease in the abundance of Leuconostocaceae was 
recorded in the faecal microbiota of humans infected by hookworms, whipworms and ascarids51, contrasting 
findings from this study and highlighting the need for further investigations in this area. In addition, the lactoba-
cilli, another group of lactic acid-producing bacteria that has been positively associated with parasite colonisation 
in rodent models of helminth infections in several recently published studies55,74–82, was not detected amongst 
the bacterial populations that were expanded in samples from S+ subjects. It must be also pointed out that, thus 
far and to the best of our knowledge, investigations conducted in human volunteers have not reported signifi-
cant shifts in the abudance of lactobacilli in the gut microbiota of helminth-infected subjects45,47,48,50–53. Whilst 
expanded populations of lactobacilli following helminth colonisation may represent a rodent-specific response 
to infection, mechanistic studies conducted, for instance, in microbiota-humanised mouse models of helminth 
infections may assist clarifying this point.
The faecal microbiota of S− subjects was enriched with a number of known opportunistic and/or potentially 
pathogenic bacteria, including Bacteroides eggerthii (higher abundances of which have been linked to increased 
risk for and severity of colitis in mice83) and species within the genus Pseudomonas. Expanded populations of 
opportunistic and potentially pathogenic microbes, coupled with an overall increase in bacterial beta diversity, 
have been described in the microbiome of aging humans84,85 and may therefore underpin our observations.
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Notably, whilst administration of ivermectin (a macrocyclic lactone) to a sub-group of S+ subjects did not 
result in significant differences in the levels of microbial alpha- and beta diversity post-anthelmintic treat-
ment (likely due to the limited number of volunteers who agreed to provide further faecal samples 6 months 
post-treatment), a tendency towards decreased alpha diversity and increased beta diversity, respectively, was 
observed in S+post-treatment samples when compared to S+pre-treatment. Nevertheless, an increase in pathogenic bac-
teria, including Enterobacteriaceae (linked to the genus Shigella) was observed in samples from S+post-treatment 
subjects when compared to S+pre-treatment. This change was also accompanied by an increase in the probiotic 
Lachnospiraceae in S+post-treatment subjects when compared to S−86, thus suggesting that anthelmintic treatment 
may have affected the taxonomic composition of the gut microbiota of previously infected subjects. Conversely, 
a recent study investigating the impact of treatment with albendazole (a benzimidazole compound) on a large 
cohort of human volunteers from Indonesia infected by ascarids, whipworms and/or hookworms, detected no 
differences between the faecal microbial composition of these volunteers and that of a placebo-treated cohort87. 
This discrepancy may be attributable to fundamental differences between the two anthelmintics investigated and/
or between parasite species assessed, and/or to sample size limitations; nevertheless, future experiments carried 
out in large cohorts of volunteers and/or in experimental models of Strongyloides infection (i.e. rodents infected 
by Strongyloides ratti) may provide further clarification.
In this study, besides determining the qualitative and quantitative composition of the gut microbiota of 
Strongyloides-infected human volunteers, we also carried out, for the first time in helminth-infected individuals, 
a comprehensive analysis of the faecal metabolome of the same subjects. Indeed, given that perturbations of the 
gut microbiota homeostasis are known to exert downstream effects on intestinal metabolism88,89, we hypothesized 
that alterations in gut microbial profiles associated to colonisation by S. stercoralis might be accompanied by 
changes in the relative abundance of individual metabolites in faecal samples, with potential implications for the 
overall health of infected individuals. Whilst analysis via NMR and GC-MS revealed no significant differences 
in the relative abundance of the vast majority of metabolites identified in samples from S+ versus S−, a number 
of amino acids (i.e. leucine, lysine, and alanine) were significantly more abundant in the faecal metabolome of 
infected individuals when compared to the uninfected cohort. Notably, anthelmintic treatment appeared to only 
affect the metabolites associated with helminth infection, i.e. amino acids, and thus may suggest that the helminth 
removal affects both the microbiome and the metabolome. An increased abundance of amino acids in the pre-
dicted faecal metabolome of helminth infected-subjects had been previously reported, albeit this information had 
been indirectly inferred from high-throughput metagenomics sequencing data50,90. Amino acids play key roles in 
the maintenance of the gut microbiome homeostasis and metabolism, since they support the growth and survival 
of bacteria in the GI tract91. Simultaneously, the gut microbiome exerts important functions in the metabolism 
of alimentary and endogenous proteins that are converted into peptides and amino acids92,93. In particular, the 
most prevalent species involved in amino acid fermentation within the human intestine are bacteria belonging to 
the class Clostridia94–96, that were more abundant in the faecal microbiota of S+ subjects. Of the amino acids that 
were significantly more abundant in the faecal metabolome of S+ subjects, lysine and leucine participate in bio-
logical pathways that are key to the maintenance of the gut homeostasis97,98. In addition, the biological functions 
of lysine and leucine are closely linked99, suggesting a possible correlation with the positive association of both 
these amino acids with the faecal metabolome of Strongyloides-infected subjects.
In contrast with the increased quantities of amino acids observed in the faecal metabolome of S+ subjects, 
the SCFAs acetate, propionate, and butyrate were significantly less abundant in this group compared to S−. This 
observation contradicts findings from a previous study in which these SCFAs were increased in faecal samples 
from human volunteers with coeliac disease and experimentally infected with the human hookworm, N. amer-
icanus49. Given the known anti-inflammatory properties of SCFAs, Zaiss et al.49 had hypothesized that these 
molecules may play a role in the therapeutic effects of GI helminths in chronic inflammatory disorders. The 
discrepancy observed between our study and that by Zaiss et al.49 may be attributable to differences between the 
cohorts of human volunteers investigated (acutely vs. chronically infected; middle aged vs. aged), species of para-
site under consideration and infection burden (known vs. unknown). In addition, both studies are characterised 
limited sample sizes that may have contributed to these contrasting results.
In summary, in our study, monospecific, chronic S. stercoralis infections were associated with global shifts 
in the composition of the human faecal microbiota, as well as subtle changes in the faecal metabolic profiles 
of these individuals when compared with those of uninfected control subjects. In addition, anthelmintic treat-
ment resulted in minor alterations of the faecal microbiota and metabolome of these volunteers 6 months 
post-administration, albeit sample size limitations prevent us from speculating on the effect/s of worm removal 
on the gut microbiota and metabolome. Future studies with longer monitoring of qualitative and qualitative 
fluctuations in faecal microbiota post-treatment may assist shedding light on this point. Whilst our findings add 
valuable knowledge to the emerging area of host-parasite-microbiota interactions, mechanistic studies in experi-
mental models of infection and disease are necessary to shed light on the likely contribution of parasite-associated 
modifications in gut microbiome and metabolism to the anti-inflammatory properties of parasitic helminths.
Methods
Ethics statement. This study was conducted according to the Declaration of Helsinki, and the protocol 
was reviewed and approved by the Institutional Ethical Review Committee for clinical experimentation for the 
Province of Verona (Comitato Etico per la Sperimentazione Clinica delle Province di Verona e Rovigo, protocol 
number 34678). Written informed consent was obtained from all subjects enrolled in the study.
Study area and characteristics of the population. Individual faecal samples from 20 volunteers (from 
4 regions in northern Italy) with confirmed infections by S. stercoralis (S+) as assessed by Real-Time PCR (rtPCR; 
cf.100), performed at the Centre for Tropical Diseases of the Sacro Cuore Hospital (Negrar, Italy) during routine 
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screening, were examined for microbiota and metabolite profiling as described below. Of these volunteers, 
15 were from the Veneto region, three from Lombardia, one from Piemonte, and one from Emilia-Romagna 
(Supplementary Fig. S1). Subjects were both men (n = 12) and women (n = 8) of an average age of 74 (range 
49–86 ± 11.5) (Supplementary Fig. S1) with no overt symptoms of GI disease and no recent history of anthel-
mintic treatment. Briefly, immediately following collection of individual faecal samples from each of these 
volunteers, aliquots (~250 mg) were examined for evidence of patent infections by GI helminths (S. stercoralis, 
Strongyloides fuelleborni, N. americanus, Ancylostoma duodenale, Trichostrongylus spp., Ternidens deminutus, and 
Oesophagostomum spp.) using the Agar Plate Copro-Culture Method (http://www.tropicalmed.eu), whilst rtPCR 
analyses were conducted to detect possible co-infections with Schistosoma spp. and Hymenolepis nana100,101. The 
remainders of each sample were stored at −80 °C for subsequent microbiota and metabolite profiling (see below). 
Patent infections by S. stercoralis were unequivocally confirmed by DNA extractions from individual faecal sam-
ples (see below) followed by rtPCR targeting the 18S rRNA gene100. Upon confirmation of diagnosis, infected vol-
unteers were treated with ivermectin (Stromectol®, Merck Sharp & Dohme BV, The Netherlands). From 13 (out 
of 20) S+ subjects (9 men and 4 women; average age of 76, range 60–84 ± 8.4, referred to as S+pre-treatment) further 
individual samples were collected 6 months post-treatment (referred to as S+post-treatment) (Supplementary Fig. S1) 
and processed as described above. Samples that were negative for patent S. stercoralis infection at this time were 
progressed to microbiota and metabolite profiling (see below). In addition, individual faecal samples from 11 
uninfected volunteers (S−) from the Veneto region (5 men and 6 women; average age of 65, range 53–86 ± 10.7; 
Supplementary Fig. S1) were included for comparative analyses. These volunteers had no overt symptoms of GI 
disease or any other concomitant disease and had no recent history of antibiotic treatment.
DNA extractions and bacterial 16S rRNA gene Illumina sequencing. Genomic DNA was extracted 
directly from 200 mg of each faecal sample using the MagnaPure LC.2 instrument (Roche Diagnostic, Monza, Italy), 
following the manufacturer’s instructions, and the DNA isolation kit I (Roche) and stored at −80 °C until further 
processing. High-throughput sequencing of the V3-V4 hypervariable region of the bacterial 16S rRNA gene was per-
formed by Eurofins Genomics on an Illumina MiSeq platform according to the standard protocols with minor adjust-
ments. Briefly, the V3-V4 region was PCR-amplified using universal primers102, that contained the adapter overhang 
nucleotide sequences for forward (TACGGGAGGCAGCAG) and reverse primers (CCAGGGTATCTAATCC). 
Amplicons were purified using AMPure XP beads (Beckman Coulter) and set up for the index PCR with Nextera 
XT index primers (Illumina). The indexed samples were purified using AMPure XP beads (Beckman Coulter) and 
quantified using the Fragment Analyzer Standard Sensitivity NGS Fragment Analysis Kit (Advanced Analytical) and 
equal quantities from each sample were pooled. The resulting pooled library was quantified using the Agilent DNA 
7500 Kit (Agilent), and sequenced using the v3 chemistry (2 × 300 bp paired-end reads, Illumina).
Bioinformatics and statistical analyses. Raw paired-end Illumina reads were trimmed for 16S rRNA 
gene primer sequences using Cutadapt (https://cutadapt.readthedocs.org/en/stable/) and sequence data were pro-
cessed using the Quantitative Insights Into Microbial Ecology 2 (QIIME2-2018.4; https://qiime2.org) software 
suite103. Successfully joined sequences were quality filtered, dereplicated, chimeras identified, and paired-end 
reads merged in QIIME2 using DADA2104. Sequences were clustered into OTUs on the basis of similarity to 
known bacterial sequences available in the Greengenes database (v13.8; http://greengenes.secondgenome.com/; 
99% sequence similarity cut-off); sequences that could not be matched to references in the Greengenes database 
were clustered de novo based on pair-wise sequence identity (99% sequence similarity cut-off). The first selected 
cluster seed was considered as the representative sequence of each OTU. The OTU table with the assigned taxon-
omy was exported from QIIME2 alongside a weighted UniFrac distance matrix. Singleton OTUs were removed 
prior to downstream analyses. Cumulative-sum scaling (CSS) was applied, followed by log2 transformation to 
account for the non-normal distribution of taxonomic counts data. Statistical analyses were executed using the 
Calypso software105 (cgenome.net/calypso/); samples were investigated using the taxonomic visualisation tool 
KRONA106 ordinated in explanatory matrices using supervised CCA including infection/treatment status as 
explanatory variables. Differences in bacterial alpha diversity (Simpson’s index) between study groups (S+ and 
S−, as well as S+pre-treatment, corresponding S+post-treatment, and S−) were evaluated based on rarefied data (read 
depth of 6063) and using analysis of variance (ANOVA); F-Tests were used to statistically assess the equality 
of assessed means (i.e. effect size). To take into account the paired nature of samples from S+pre-treatment and 
S+post-treatment, differences between these sets were assessed using linear mixed effect regression. Differences in 
beta diversity (weighted UniFrac distances) were identified using Analysis of Similarity (ANOSIM) and effect size 
indicated by an R-value (between −1 and + l, with a value of 0 representing the null hypothesis107). Differences 
in the abundance of individual microbial taxa between groups were assessed using the LEfSe workflow108, taking 
into account the paired nature of S+pre-treatment and S+post-treatment samples.
Metabolite extraction. Metabolites were extracted from 200 mg aliquots of each faecal sample using a 
methanol–chloroform–water (2:2:1) procedure. 600 μl of methanol–chloroform mix (2:1 v:v) were added, sam-
ples were homogenised using stainless steel beads and sonicated for 15 min at room temperature. 200 μl each 
of chloroform and water were added, the samples were centrifuged and the separated aqueous and lipid phases 
were collected. The procedure was repeated twice, and the aqueous and lipid fractions from each extraction were 
pooled. The aqueous layer was dried in a vacuum concentrator (Concentrator Plus, Eppendorf), while the lipid 
fraction was left to dry overnight at room temperature.
Nuclear Magnetic Resonance analysis of aqueous extracts. The dried aqueous fractions were 
re-dissolved in 600 μl D2O, containing 0.2 mM sodium-3-(tri-methylsilyl)−2,2,3,3-tetradeuteriopropionate 
(TSP) (Cambridge Isotope Laboratories, MA, USA) as an internal standard and phosphate buffer (40 mM 
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NaH2PO4/160 mM Na2HPO4). The samples were analysed using an AVANCE II+NMR spectrometer operating 
at 500.13 MHz for the 1H frequency and 125.721 MHz for the 13C frequency (Bruker, Germany) using a 5 mm 
TXI probe. The instrument is equipped with TopSpin 3.2. Spectra were collected using a solvent suppression 
pulse sequence based on a one-dimensional nuclear Overhauser effect spectroscopy (NOESY) pulse sequence to 
saturate the residual 1 H water signal (relaxation delay = 2 s, t1 increment = 3 us, mixing time = 150 ms, solvent 
pre-saturation applied during the relaxation time and the mixing time). One hundred and twenty-eight transients 
were collected into 16 K data points over a spectral width of 12 ppm at 27 °C. In addition, representative samples 
of each data set were also examined by two-dimensional Correlation Spectroscopy (COSY), using a standard 
pulse sequence (cosygpprqf) and 0.5 s water presaturation during relaxation delay, 8 kHz spectral width, 2048 
data points, 32 scans per increment, 512 increments. Peaks were assigned using the COSY spectra in conjunction 
with reference to previous literature and databases and the Chenomx spectral database contained in Chenomx 
NMR Suite 7.7 (Chenomx, Alberta, Canada). 1D-NMR spectra were processed using TopSpin. Free induction 
decays were Fourier transformed following multiplication by a line broadening of 1 Hz, and referenced to TSP 
at 0.0 ppm. Spectra were phased and baseline corrected manually. The integrals of the different metabolites were 
obtained using Chenomx. Metabolites were normalised to total area and differential abundance of metabolites 
between S+ and S− subjects, as well as S+post-treatment and S− subjects identified using ANOVA. F-Tests were used 
to statistically assess the equality of assessed means, while differences between S+pre-treatment and S+post-treatment were 
determined through paired t-test to account for the paired nature of these samples. Associations among metab-
olites in the faecal metabolome of each sample group were identified by prediction of correlation networks in 
Calypso105 (cgenome.net/calypso/). In particular, networks were constructed to identify clusters of co-occurring 
metabolites based on their association with infection status (i.e., samples from S+ and S−, as well as S+pre-treatment, 
S+post-treatment and S− subjects). Metabolites and explanatory variables were represented as nodes, relative abun-
dance as node size, and edges represented positive associations, while nodes were coloured according to infection 
status. Metabolite abundances were associated with infection status using Pearson’s correlation. Nodes were then 
coloured based on the strength of the association (i.e. Spearman’s rho correlation) with infection status. Networks 
were generated by computing associations between taxa using Spearman’s rho and the resulting pairwise corre-
lations were converted into dissimilarities and then used to ordinate nodes in a two-dimensional plot by PCoA. 
Therefore, correlating nodes were located in close proximity and anti-correlating nodes were placed at distant 
locations in the network.
Gas Chromatography–Mass Spectrometry analysis of organic extracts. 100 μl of D-25 tridecanoic 
acid (200 μM in chloroform), 650 μl of chloroform/methanol (1:1 v/v) and 125 μl BF3/methanol (Sigma-Aldrich) 
were added to 100 μl organic extract dissolved in chloroform/methanol (1:1 v/v) (half of the organic material 
extracted for each sample). The samples were then incubated at 80 °C for 90 min. 500 μl H2O and 1 ml hexane 
were added and each vial mixed and the two phases separated. The organic layer was evaporated to dryness before 
reconstitution in 200 μl hexane for analysis. Using a Trace GC Ultra coupled to a Trace DSQ II mass spectrome-
ter (Thermo Scientific, Hemel Hempstead, UK), 2 μl of the derivatised organic metabolites were injected onto a 
TR-fatty acid methyl ester (FAME) stationary phase column (Thermo Electron; 30 m × 0.25 mm ID × 0.25 μm; 
70% cyanopropyl polysilphenylene-siloxane) with a split ratio of 20. The injector temperature was 230 °C and the 
helium carrier gas flow rate was 1.2 ml/min. The column temperature was 60 °C for 2 min, increased by 15 °C/
min to 150 °C, and then increased at a rate of 4 °C/min to 230 °C (transfer line = 240 °C; ion source = 250 °C, 
EI = 70 eV). The detector was turned on after 240 s, and full-scan spectra were collected using 3 scans/s over a 
range of 50–650 m/z. Peaks were assigned using Food Industry FAME Mix (Restek 6098). GC–MS chromato-
grams were analysed using Xcalibur, version 2.0 (Thermo Fisher), integrating each peak individually, and nor-
malised to total area. The set of metabolic profiles obtained were analysed by univariate analysis. Differential 
abundance of metabolites between analysis groups was identified using ANOVA, and F-Tests were used to statis-
tically assess the equality of assessed means. Associations among metabolites identified in the faecal metabolome 
of each sample group were identified by prediction of correlation networks in Calypso105 (cgenome.net/calypso/).
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